Gleason Shane Thomas 4

What Happened
Shane Gleason, Chief Commercial Officer of InspireMD (NSPR), reported ten open-market sales between Jan 15 and Feb 2, 2026, disposing of a total of 61,194 common shares for aggregate proceeds of approximately $99,330. Individual sales ranged from 2,000 to 17,593 shares at prices between $1.57 and $1.66 per share. These were sales (S) — not purchases — and were executed to cover tax withholding on vested restricted stock (see footnote).

Key Details

• Transaction dates & prices (summary): Jan 15–Feb 2, 2026; per-share prices ranged $1.57–$1.66. Proceeds by trade totaled roughly $4.6k, $3.6k, $4.7k, $28.6k, $13.2k, $8.0k, $20.5k, $8.3k, $4.7k and $3.2k respectively. Aggregate: 61,194 shares for ~$99,330.
• Shares owned after transaction: Not specified in this filing.
• Footnote: F1 states these were sell-to-cover transactions required to satisfy tax withholding arising from vesting of restricted stock; sales were per an automatic sell-to-cover instruction adopted Nov 25, 2024 and “do not represent discretionary trades.”
• Filing: Form 4 filed Feb 2, 2026 (transactions occurred Jan 15–Feb 2); earlier trades appear to fall outside the typical two-business-day Form 4 reporting window for officers, so check for any prior filings or explanatory amendments.
• Exhibit: 24.1 Power of Attorney attached.

Context
Sell-to-cover transactions are common when restricted stock vests and are routine tax-related dispositions; they generally should not be interpreted as a bullish or bearish signal about the company's prospects. The filing lists code S (sale) and footnote F (tax withholding).